Tumor regression and modulation of gene expression via tumor-targeted tocotrienol niosomes.

about

Tumor regression and modulation of gene expression via tumor-targeted tocotrienol niosomes.

Item

http://www.wikidata.org/entity/Q51779252

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tumor regression and modulatio ...... targeted tocotrienol niosomes.

@en

Tumor regression and modulatio ...... targeted tocotrienol niosomes.

@nl

type

Item

label

Tumor regression and modulatio ...... targeted tocotrienol niosomes.

@en

Tumor regression and modulatio ...... targeted tocotrienol niosomes.

@nl

prefLabel

Tumor regression and modulatio ...... targeted tocotrienol niosomes.

@en

Tumor regression and modulatio ...... targeted tocotrienol niosomes.

@nl

P1476

Tumor regression and modulatio ...... -targeted tocotrienol niosomes

@en

P2093

Doryn Meam-Yee Tan

http://www.w3.org/2001/XMLSchema#string

Fu-Shun Wong

http://www.w3.org/2001/XMLSchema#string

Ju-Yen Fu

http://www.w3.org/2001/XMLSchema#string

Kalanithi Nesaretnam

http://www.w3.org/2001/XMLSchema#string

Yu-Sui Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Bioavailability of tocotrienols: evidence in human studies

Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols

Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells

Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells

Triple-negative breast cancer: an unmet medical need

Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status.

Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts.

Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.

P304

2487-2502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM-2017-0182

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hui Meng Er

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28972460

http://www.w3.org/2001/XMLSchema#string